West Pharmaceutical Services Q2 2026: Strong Sales, Profit Growth and a Clear Path to Mid‑$3B Revenue
West Pharmaceutical Services Q2 2026: $800 M net sales, $2.00+ EPS, strong cash flow, and a mid‑$3 B sales outlook driven by high‑growth injectable drug demand.
- WEST PHARMACEUTICAL SERVICES
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
4 minutes to read